No Data
Unicycive Therapeutics to Participate in Two Upcoming Investor Conferences Including a Fireside Chat at the Piper Sandler 36th Annual Healthcare Conference
Maxim Group Maintains Unicycive Therapeutics(UNCY.US) With Buy Rating, Announces Target Price $2
Express News | Unicycive Therapeutics Inc Files for Mixed Shelf of up to $100 Mln - SEC Filing
Express News | Unicycive Therapeutics Inc Q3 Shr View $-0.15 -- LSEG IBES Data
Unicycive Therapeutics 3Q Loss/Shr 5c >UNCY
Press Release: Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update
No Data
No Data